Ginger Yu Fei Jiang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insurance Coverage | 2 | 2023 | 1895 | 0.470 |
Why?
|
| Medicaid | 3 | 2023 | 2716 | 0.460 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2023 | 1208 | 0.440 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2022 | 1415 | 0.430 |
Why?
|
| Heart Failure | 3 | 2023 | 10856 | 0.370 |
Why?
|
| Medicare | 2 | 2023 | 6532 | 0.320 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 5019 | 0.230 |
Why?
|
| Diuresis | 1 | 2023 | 116 | 0.230 |
Why?
|
| Diuretics | 1 | 2023 | 591 | 0.180 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 15108 | 0.170 |
Why?
|
| Government Programs | 1 | 2020 | 275 | 0.160 |
Why?
|
| Economics, Hospital | 1 | 2020 | 213 | 0.160 |
Why?
|
| Policy | 1 | 2022 | 504 | 0.150 |
Why?
|
| Carbazoles | 1 | 2018 | 226 | 0.150 |
Why?
|
| Quality of Health Care | 2 | 2020 | 4369 | 0.120 |
Why?
|
| United States | 5 | 2023 | 69693 | 0.110 |
Why?
|
| Poverty | 1 | 2023 | 2646 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2012 | 187 | 0.100 |
Why?
|
| Patient Discharge | 1 | 2023 | 3300 | 0.090 |
Why?
|
| Piperidines | 1 | 2018 | 1602 | 0.090 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 3656 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 1581 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1831 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5171 | 0.090 |
Why?
|
| Stroke Volume | 1 | 2022 | 4983 | 0.090 |
Why?
|
| Cardiology | 1 | 2020 | 1658 | 0.080 |
Why?
|
| Hospitalization | 2 | 2023 | 10232 | 0.070 |
Why?
|
| Hospitals | 1 | 2020 | 3937 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 1 | 2012 | 879 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 5133 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3151 | 0.060 |
Why?
|
| Prognosis | 2 | 2022 | 29010 | 0.060 |
Why?
|
| Aged | 5 | 2023 | 162944 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13019 | 0.060 |
Why?
|
| Learning | 1 | 2012 | 1705 | 0.050 |
Why?
|
| Memory | 1 | 2012 | 2163 | 0.050 |
Why?
|
| Humans | 8 | 2023 | 742088 | 0.050 |
Why?
|
| Pregnancy | 1 | 2022 | 29087 | 0.040 |
Why?
|
| Hippocampus | 1 | 2012 | 3661 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 77098 | 0.040 |
Why?
|
| Female | 6 | 2022 | 379592 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8829 | 0.040 |
Why?
|
| Hospital Mortality | 2 | 2020 | 5310 | 0.030 |
Why?
|
| American Heart Association | 1 | 2020 | 1055 | 0.030 |
Why?
|
| Male | 5 | 2022 | 349538 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 2281 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 24913 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4839 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2020 | 4567 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12773 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2012 | 1882 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6365 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5163 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 56350 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5522 | 0.010 |
Why?
|
| Middle Aged | 3 | 2020 | 213127 | 0.010 |
Why?
|
| Adult | 3 | 2020 | 213712 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14554 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57683 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 29717 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 72145 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 62966 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 81045 | 0.000 |
Why?
|
| Animals | 1 | 2012 | 168561 | 0.000 |
Why?
|